Methodology
This page documents how every BalancePhase review is produced: what we assess, how we verify it, and — importantly — what we do not do.
We publish this because a review is only useful if the reader understands how the verdict was reached. If our method does not hold up to your scrutiny, the conclusion should not either.
How a product reaches review
BalancePhase does not review every supplement on the market. Products enter our pipeline through three routes:
- Reader demand. Products that generate repeated search interest in our covered markets, or that readers ask us about directly.
- Market activity. Products with active advertising presence in the US, UK or EU supplement categories — these are the products consumers are being actively sold, and therefore the ones most in need of independent assessment.
- Category gaps. Categories where existing consumer information is thin or dominated by marketing material rather than analysis.
Commercial relationships do not determine which products we review. A product with no affiliate programme can and does enter our pipeline; a product with an attractive commission rate is not reviewed unless it meets the criteria above.
Assessment criteria
Each product is assessed against five criteria. These are applied consistently across every review published on the site.
1. Ingredient disclosure
Is every active ingredient listed with its exact quantity? Proprietary blends that conceal individual doses are recorded as a disclosure failure, regardless of whether the ingredients themselves are promising.
2. Claim substantiation
Are the marketing claims authorised health claims under FDA, EFSA or MHRA rules? Claims that borrow clinical language without a citation are flagged. Where a claim is technically permitted but weakly supported by the underlying evidence, we say so.
3. Pricing transparency
What is the true cost of the product over a realistic period of use? We separate the advertised headline price from subscription renewal terms, shipping costs and cancellation conditions. Subscription traps are recorded explicitly.
4. Manufacturer accountability
Is the manufacturer identifiable? Does the label carry a verifiable business address? Are third-party testing certificates published? Products from anonymous or untraceable sellers are treated with corresponding caution.
5. Evidence alignment
Does the formula match what the published literature says about the ingredients in question — dose, form and combination? A formula containing the right ingredient at an ineffective dose is not a good formula, and we treat it accordingly.
How we weight the criteria
Not every criterion carries equal weight. The table below shows how each contributes to the overall assessment.
| Criterion | Weight | Reasoning |
|---|---|---|
| Ingredient disclosure | 30% | Without a disclosed formula, no other assessment is meaningful. |
| Claim substantiation | 25% | Misleading claims are the most common consumer harm in this market. |
| Pricing transparency | 20% | Much of the real cost of this category sits in subscription terms. |
| Evidence alignment | 15% | Formula quality matters, but a good formula does not compensate for a hidden one. |
| Manufacturer accountability | 10% | Traceability is necessary but rarely the deciding factor on its own. |
How we verify
Verification follows the same sequence in every review:
- Primary source first. The product label, the manufacturer's own published documentation and the regulatory register take precedence over secondary coverage.
- Regulatory cross-check. Health claims are checked against the FDA structure/function claim notification database, the EFSA Register of authorised health claims, and MHRA guidance for the UK market. A claim permitted in one market is not assumed permitted in another.
- Literature check. Where we discuss ingredient efficacy, we cite published research. We do not cite a study we have not read, and we do not present a single small trial as settled consensus.
- Pricing verification. Subscription terms are checked on the checkout page rather than the marketing page, because the two frequently differ.
What we do not do
BalancePhase has no laboratory and does not commission third-party assays of the products we review. When we reference a laboratory result, it is a result published by someone else, and we name the source. When no independent testing exists for a product, our review states that explicitly rather than implying verification we have not performed.
Our reviews assess products as consumer goods — formula, claims, price and traceability. We do not assess whether a supplement is appropriate for your personal health situation, and nothing on this site should be read as a recommendation to take or avoid any product for medical reasons. That determination belongs with a qualified healthcare professional who knows your history.
We also do not:
- Publish reviews of products we have not examined against all five criteria
- Accept payment for a positive assessment, or allow a commercial partner to review content before publication
- Present an affiliate relationship as editorial endorsement
- Reuse marketing copy as our own analysis
When a product is poor
A meaningful share of what we review does not deserve a purchase recommendation. When a product fails on disclosure, pricing transparency or claim substantiation, we publish that assessment with the same prominence as a positive one — including a clear statement that we do not recommend it.
This is not an incidental feature of our method. A review publication that never reaches negative conclusions is not conducting reviews; it is producing marketing. Our readers should be able to tell the difference.
Updates and dates
Products change. Formulas are reformulated, prices change, subscription terms are altered and regulatory positions move. Every review carries a visible publication date and a last-updated date. When a substantive change is made to a review, the update is noted in the article with a short explanation of what changed and why.
If you spot a review that appears out of date, tell us at editorial@balancephase.com.
Corrections
Factual errors are corrected promptly and transparently. Where a correction changes the substance of an assessment, the correction is noted at the top of the article rather than quietly edited into the text. Our correction process is described in full in the Editorial Policy.
Related pages
This methodology should be read alongside our Editorial Policy (independence, corrections and use of AI) and our Affiliate Disclosure (how the site is funded).